Ce radionucléide est sélectionné dans le groupe constitué des Radium-223, Radium-224, Radon-219 et Radon-220.
A radiotherapy method, comprising positioning a predetermined amount of a radionuclide selected from the group consisting of Radium-223, Radium-224, Radon-219 and Radon-220, in proximity to and/or within a tumor of a subject, for a predetermined time period.patents-wipo patents-wipo